GRAMD1B and myeloid sarcoma: We further decided to assess the aggregate effect of rare functional variants in the GRAMD1B gene using two burden tests (adaptive sum [55] and C-alpha [56]), and we compared the familial cases (91 unrelated MS patients and the proband from the described family) to 62 HCs who underwent whole exome sequencing using the same protocol.